Publisher Correction: Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer

• Mathilde Louise Gehrchen,
• Tobias Berg,
• Rasmus Garly,
• Maj-Britt Jensen,
• Saskia Eßer-Naumann,
• Jeanette Dupont Rønlev,
• Hanne Melgaard Nielsen,
• Ann Knoop,
• Iben Kümler

Affiliations

Mathilde Louise Gehrchen

Danish Breast Cancer Group, Department of Oncology, Copenhagen University Hospital, Rigshospitalet

Tobias Berg

Danish Breast Cancer Group, Department of Oncology, Copenhagen University Hospital, Rigshospitalet

Rasmus Garly

Danish Breast Cancer Group, Department of Oncology, Copenhagen University Hospital, Rigshospitalet

Maj-Britt Jensen

Danish Breast Cancer Group, Department of Oncology, Copenhagen University Hospital, Rigshospitalet

Saskia Eßer-Naumann

Department of Oncology, Næstved Hospital

Jeanette Dupont Rønlev

Department of Oncology, University Hospital of Odense

Hanne Melgaard Nielsen

Department of Oncology, Aarhus University Hospital

Ann Knoop

Danish Breast Cancer Group, Department of Oncology, Copenhagen University Hospital, Rigshospitalet

Iben Kümler

Department of Oncology, Herlev and Gentofte University Hospital